BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2061103)

  • 1. The Bethesda system for the reporting of cervical/vaginal cytology.
    Oren A; Fernandes J
    J Am Osteopath Assoc; 1991 May; 91(5):476-9. PubMed ID: 2061103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening.
    Holcomb K; Runowicz CD
    Surg Oncol Clin N Am; 2005 Oct; 14(4):777-97. PubMed ID: 16226691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimally abnormal Papanicolaou smear.
    Brotzman GL; Julian TM
    Am Fam Physician; 1996 Mar; 53(4):1154-62. PubMed ID: 8629563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cytology.
    Beal MW
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1990; 1(4):470-8. PubMed ID: 2081083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New classification in cervical cytology: the Bethesda system].
    Bodó M; Tóth V
    Orv Hetil; 1991 May; 132(19):1039-40. PubMed ID: 2027678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of repeat cytology at the time of colposcopy for the evaluation of cervical intraepithelial neoplasia on Papanicolaou smears.
    Wheelock JB; Kaminski PF
    J Reprod Med; 1989 Oct; 34(10):815-7. PubMed ID: 2795564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-negative cytology rates in patients in whom invasive cervical cancer subsequently developed.
    Morell ND; Taylor JR; Snyder RN; Ziel HK; Saltz A; Willie S
    Obstet Gynecol; 1982 Jul; 60(1):41-5. PubMed ID: 7088449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bethesda system for classification of Pap smears: the clinical experience of one cancer screening center.
    Mahon SM
    Cancer Nurs; 1995 Dec; 18(6):458-66. PubMed ID: 8564942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pitfalls of cervical cancer screening.
    Sedlis A
    Contrib Gynecol Obstet; 1991; 18():103-14. PubMed ID: 1657521
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of the screening history of Alberta women with invasive cervical cancer.
    Stuart GC; McGregor SE; Duggan MA; Nation JG
    CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
    Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
    Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing cytologic detection rates for cervical intraepithelial neoplasia and invasive cancer in a population lacking a mass screening program.
    Frangopoulou E; Linos A; Mentzelopoulou P; Papaefthimiou M; Efstratiadou M
    Acta Cytol; 1989; 33(6):839-42. PubMed ID: 2588916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cytology and the evaluation of the abnormal Papanicolaou smear.
    Noller KL
    Prim Care; 1988 Sep; 15(3):461-71. PubMed ID: 3054958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary study concerning the cytoscreen system importance (liquid based cytology) in gynecologic cytology.
    Popescu CF; Bădulescu A; Bădulescu F; Cotarcea S; Găvănescu M
    Rom J Morphol Embryol; 2005; 46(1):23-7. PubMed ID: 16286981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-positive squamous cell carcinoma in cervical smears: cytologic-histologic correlation in 19 cases.
    Levine PH; Elgert PA; Mittal K
    Diagn Cytopathol; 2003 Jan; 28(1):23-7. PubMed ID: 12508178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 1988 Bethesda system for cervical vaginal cytology: pros and cons.
    Barlow JF
    S D J Med; 1991 Jun; 44(6):157-8. PubMed ID: 1658929
    [No Abstract]   [Full Text] [Related]  

  • 19. Pap smear update--the Bethesda (nomenclature) System.
    Piper DM
    West J Med; 1991 Mar; 154(3):325. PubMed ID: 2028595
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytodiagnosis in cervical neoplasia: from the Babes/Papanicolaou smear to the actual Bethesda System.
    Virtej P; Vasiliu C
    Clin Exp Obstet Gynecol; 2003; 30(4):173-7. PubMed ID: 14664403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.